Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection - Milighetti, M; Peng, Y; Tan, C; Mark, M; Nageswaran, G; Byrne, S; Ronel, T; Peacock, T; Mayer, A; Chandran, A; Rosenheim, J; Whelan, M; et al. (iScience, 2023)